BIO to Host New Clean Tech Investor Sessions for VCs at the World Congress on Industrial Biotechnology and Bioprocessing

WASHINGTON, D.C. (Wednesday, June 16, 2010) - Industrial biotechnology companies are leading the drive to commercialize advanced biofuels, renewable chemicals and biobased products, generating new opportunities economic growth. The Biotechnology Industry Organization (BIO) today announced creation of a first-of-its-kind Clean Tech Investor Session Program, featuring industrial biotech companies. This new two-day clean tech investor program will be held June 28-29, during the 2010 World Congress on Industrial Biotechnology & Bioprocessing in Washington, DC.

Brent Erickson, executive vice president for BIO’s Industrial and Environmental Section, stated, “Industrial biotechnology is bringing renewed innovation to the chemical industry. Deployment of the technology can restore U.S. economic competitiveness in the chemical industry, contribute to renewed, sustainable economic growth, and create or save jobs in the sector. The United States is a world leader in developing industrial biotechnology for biobased products and green chemicals, but other countries are investing to promote this sector.

“BIO is proud to announce the first-ever investor sessions at the World Congress on Industrial Biotechnology & Bioprocessing. Executives from emerging industrial biotechnology companies seeking investment and partnering opportunities will present their new technologies, accomplishments, milestones, value propositions and business cases for advanced biofuels and renewable chemical platforms. Innovative industrial biotechnology companies were selected to participate in this program based on their breakthrough clean technologies, bio-based consumer product strategies, and extensive intellectual property coverage.”

Companies selected to present to investors include:


The new upgraded BIO One-on-One Partnering System will allow investors and biotechnology companies to schedule private meetings.

Attendance at the Investor Sessions and the exhibit hall is complimentary for investors or security analysts. Investors will be required to obtain full conference registration to attend plenary and breakout sessions at the World Congress. Please send an email to Alex Matthews,, to pre-register.

The Seventh Annual World Congress on Industrial Biotechnology & Bioprocessing takes place June 27-30, 2010, at the Gaylord National Resort & Convention Center in Washington, DC. The World Congress– co-organized by BIO, BIOTECanada, and the U.S. Department of Energy – is the original and only conference dedicated solely to industrial biotechnology and the most recent advancements in the field. Early-bird registration ends April 14, 2010. Visit

Registration for the World Congress is now open and is complimentary for credentialed members of the news media. All programs at the World Congress on Industrial Biotechnology & Bioprocessing are open to attendance by members of the media. Reporters and editors working full-time for print, broadcast, and online news organizations may register onsite with valid media credentials. All freelancers, college and online publications are strongly encouraged to register in advance. For more information, please visit

Upcoming BIO Events

World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC

BIO India
September 21 - 22, 2010
Hyderabad, India

BIO’s Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD

BIO Investor Forum
October 5-6, 2010
San Francisco, CA
BIO Intellectual Property Counsels Committee Fall Conference and Committee Meeting
October 18-20, 2010
Boston, MA


 About BIO

BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.